cyclosporine has been researched along with Multiple Myeloma in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 22 (43.14) | 18.2507 |
| 2000's | 20 (39.22) | 29.6817 |
| 2010's | 9 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, S; Choi, EJ; Choi, Y; Jeon, M; Jo, JC; Joo, YD; Kang, YA; Kang, YL; Kim, DY; Kim, H; Kim, SH; Ko, SH; Lee, JH; Lee, KH; Lee, YS; Lim, SN; Park, HS; Seol, M; Yun, SC | 1 |
| Alimoghaddam, K; Khodabakhsh, A; Nafissi, S; Sinaei, F | 1 |
| Aggarwal, R; Dogra, S; Handa, S; Malhotra, P; Muhammed, H; Razmi T, M; Saikia, UN; Sharma, S | 1 |
| Bardia, A; Mathivanan, BR; Nalwa, A; Singh, S | 1 |
| Caballero, D; Caballero-Velázquez, T; Castilla-Llorente, C; Encinas, C; Heras, I; López-Corral, L; Martino, R; Pérez-Simón, JA; Rosiñol, L; Sampol, A; San Miguel, J; Serrano, D | 1 |
| Abramson, AK; Day, A; Menter, MA; Patel, M; Warren, RB | 1 |
| Chen, JA; Hsu, JH; Lin, KC; Lin, ZL; Wu, HJ | 1 |
| Adachi, D; Hattori, N; Nakamaki, T; Nakashima, H; Saito, B; Tomoyasu, S | 1 |
| Choi, SJ; Chung, IJ; Chung, SY; Jin, CJ; Kang, HK; Kim, HJ; Kim, SK; Kim, YK; Lee, JJ; Nam, JH; Nguyen Hoang, TM; Nguyen Pham, TN; Yang, DH | 1 |
| Fox, LP; Goddard, DS; Mathes, ED; Nixon, M; Ruben, BS; Wolf, J | 1 |
| Bruijnen, CP; Cornelisse, PB; Cornelissen, JJ; Emmelot, M; Huisman, C; Huls, G; Janssen, JJ; Kersten, MJ; Kneppers, E; Lokhorst, HM; Meijer, E; Minnema, MC; Mutis, T; Sonneveld, P; van der Holt, B; Zweegman, S | 1 |
| Cheng, LL; Jon, HC; Kwok, AK; Lam, DS; Neoh, EL; Wat, NM | 1 |
| Bader, P; Bamberg, M; Einsele, H; Faul, C; Hebart, H; Kanz, L; Liebisch, P; Meisner, C; Plasswilm, L; Schäfer, HJ | 1 |
| Benner, A; Goerner, M; Ho, AD; Hoepfner, S; Luft, T; Weber-Nordt, R | 1 |
| Anagnostopoulos, A; Anastasiou-Nana, MI; Dimopoulos, AM; Matsouka, C; Terrovitis, JV | 1 |
| Aouali, N; Eddabra, L; Macadré, J; Morjani, H | 1 |
| Laport, G; Lowsky, R; Tong, J | 1 |
| Chim, CS; Ooi, GC | 1 |
| Atanackovic, D; Ayuk, F; Kröger, N; Renges, H; Schieder, H; Zabelina, T; Zander, A | 1 |
| Boccadoro, M; Bruno, B; Carnevale-Schianca, F; Corradini, P; Fanin, R; Giaccone, L; Guidi, S; Mattei, D; Milone, G; Montefusco, V; Patriarca, F; Peccatori, J; Petrucci, MT; Rotta, M; Sorasio, R | 1 |
| Bertz, H; Finke, J; Grüllich, C; Müller, CI; Spyridonidis, A | 1 |
| Denisova, V; Gilevich, A; Kozhevnikov, V; Kozlov, V; Kruchkova, I; Kulagin, A; Lisukov, I; Pronkina, N; Sizikova, S | 1 |
| Belch, AR; Pilarski, LM | 1 |
| de Leeuw, K; Schoester, M; Sonneveld, P | 1 |
| Dutcher, JP; Leaf, AN; Liao, Z; Paietta, E; Rosenstreich, DL; Wiernik, PH | 1 |
| Delmer, A; Marie, JP; Zhou, D; Zittoun, R | 1 |
| Dalton, WS; de Giuli, R; Emerson, S; Lehnert, M; Salmon, SE | 1 |
| Fullard, L; Hale, G; Jacobs, P; Waldmann, H; Wood, L | 1 |
| Abbal, M; Durand, D; Modesto, A; Rostaing, L | 1 |
| Alexanian, R; Dimopoulos, MA; Weber, DM | 1 |
| Adam, Z; Vorlícek, J | 1 |
| Alexanian, R; Dimopoulos, M; Sinicrope, F; Weber, D | 1 |
| Cremer, PD; Forsyth, CJ; Iland, HJ; Torzillo, P; Young, GA | 1 |
| Bellamy, WT; Ellsworth, L; Grogan, TM; Odeleye, A; Peng, YM; Weinstein, RS; Xu, MJ | 1 |
| Alexanian, R; Andersson, B; Champlin, R; Colome, M; Delasalle, K; Dimopoulos, M; Gajewski, J; Giralt, S; Khouri, I; Korbling, M; Mehra, R; Przepiorka, D; Seong, D; Van Besien, K; von Wolff, B; Weber, D | 1 |
| Belch, AR; Murphy, GF; Pilarski, LM; Yatscoff, RW | 1 |
| Boccadoro, M; Caracciolo, D; Cavallaro, AM; Corradini, P; Indovina, A; Majolino, I; Marcenò, R; Palumbo, A; Pileri, A; Santoro, A; Scimè, R; Tarella, C | 1 |
| Bartels, P; Buell, DN; Erdman, J; Fitzsimmons, WE; Hodosh, E; Horowitz, MM; Huang, C; Maher, R; Przepiorka, D; Wingard, JR; Zhang, MJ | 1 |
| Bergna, MI; Cánepa, C; Gardenal, L; Gil, MA; Italiano, C; Klein, G; Malacalza, J; Mansilla, E; Marin, GH; Mendez, MC; Menna, ME; Orlando, S; Perez, M; Piccinelli, G; Saba, S | 1 |
| Baron, F; Beguin, Y; Fillet, G; Gothot, A; Hermanne, JP; Pierard, GE; Salmon, JP | 1 |
| Durrant, S; Irving, I; Mollee, P; Morton, AJ | 1 |
| Appelbaum, FR; Bensinger, WI; Blume, KG; Bryant, E; Chauncey, TR; Flowers, ME; Georges, GE; Gooley, TA; Grumet, FC; Hegenbart, U; Kiem, HP; Maloney, DG; McSweeney, PA; Minor, S; Molina, AJ; Nash, RA; Niederwieser, D; Radich, J; Sandmaier, BM; Shizuru, JA; Storb, RF; Torok-Storb, B; Wagner, JL; Yu, C | 1 |
| Buzio, C; Cardarelli, F; Olivetti, G; Rossi, L; Vampa, ML | 1 |
| Derigs, HG; Fischer, T; Huber, C; Kolbe, K; Kreiter, S; Schneider, PM; Schuler, M; Ullmann, AJ; Winkelmann, N | 1 |
| Chan, GZ; Kapoor, M | 1 |
| Beksac, M; Dohner, H; Gerhartz, H; Lokhorst, H; Lowenberg, B; Neuwirtova, R; Segeren, CM; Solbu, G; Sonneveld, P; Suciu, S; van der Lelie, J; Weijermans, P; Willemze, R | 1 |
| Durie, BG; Lokhorst, HM; Löwenberg, B; Marie, JP; Nooter, K; Solbu, G; Sonneveld, P; Suciu, S; Zittoun, R | 1 |
| Jonsson, B; Larsson, R; Nilsson, K; Nygren, P | 1 |
| Hess, AD; Horwitz, L; Kim, H; Laulis, MK; Noga, SJ | 1 |
| Burtin, P; Guerci, AP; Lederlin, P; Mattei, S | 1 |
| Andersson, BS; Brunner, LJ; Deisseroth, AB; Dimopoulos, MA; Huan, SD; Spencer, V; Spitzer, G; Wallerstein, RO; Woo, SY; Yau, JC | 1 |
6 review(s) available for cyclosporine and Multiple Myeloma
| Article | Year |
|---|---|
The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease.
Topics: Aortic Coarctation; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Comorbidity; Cyclosporine; Dermatologic Agents; Eye Abnormalities; Eye Diseases; Eyelid Neoplasms; Humans; Lymphoma, T-Cell, Cutaneous; Melanoma; Mohs Surgery; Multiple Myeloma; Neurocutaneous Syndromes; Retinoids; Sebaceous Gland Neoplasms; Skin Diseases; Skin Neoplasms; Stevens-Johnson Syndrome; Syndrome; Tumor Necrosis Factor-alpha | 2014 |
Immunosuppressors and reversion of multidrug-resistance.
Topics: Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Ceramides; Cyclosporine; Cyclosporins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Immunosuppressive Agents; Multiple Myeloma; Piperidines; Pyridines | 2005 |
[Trials of modulating the MDR1 phenotype in malignant hemopathies].
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Dexamethasone; Doxorubicin; Drug Resistance, Multiple; Humans; Leukemia, Myeloid, Acute; Multiple Myeloma; Quinine; Verapamil; Vincristine | 1994 |
[Resistance to cytostatic agents in patients with refractory multiple myeloma and possible ways to control it].
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cyclosporine; Drug Resistance; Humans; Membrane Glycoproteins; Multiple Myeloma; Verapamil | 1993 |
Membranous glomerulonephritis after haematopoietic cell transplantation for multiple myeloma.
Topics: Cyclosporine; Glomerulonephritis, Membranous; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Myeloma; Nephrotic Syndrome | 2001 |
Malignancy and renal disease.
Topics: Acute Kidney Injury; Antineoplastic Agents; Bone Marrow Transplantation; Cisplatin; Cyclosporine; Hepatorenal Syndrome; Humans; Kidney Diseases; Methotrexate; Multiple Myeloma; Neoplasms; Renal Replacement Therapy | 2001 |
14 trial(s) available for cyclosporine and Multiple Myeloma
| Article | Year |
|---|---|
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Prospective Studies; Recurrence; Remission Induction; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Haploidentical; Unrelated Donors; Vidarabine | 2017 |
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclosporine; Drug Synergism; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Male; Melphalan; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Peripheral Nervous System Diseases; Protease Inhibitors; Pyrazines; Remission Induction; Reoperation; Salvage Therapy; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Vidarabine | 2013 |
Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Drug Eruptions; Feasibility Studies; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Immunosuppressive Agents; Lenalidomide; Lymphocyte Count; Male; Melphalan; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Prospective Studies; Remission Induction; Thalidomide; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation | 2011 |
Addition of a low fixed number of CD3+ cells to CD34-enriched allografts: effects on engraftment, graft-versus-host disease, and survival after related and unrelated peripheral stem cell transplantation.
Topics: Adult; Antigens, CD; Antigens, CD34; CD3 Complex; Cell Separation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Stem Cell Transplantation; Survival Analysis; Time Factors; Transplantation, Homologous | 2003 |
Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission status.
Topics: Adult; Antineoplastic Agents; Boronic Acids; Bortezomib; CD3 Complex; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Herpes Zoster; Humans; Leukopenia; Male; Middle Aged; Multiple Myeloma; Prospective Studies; Pyrazines; Remission Induction; Stem Cell Transplantation; Thrombocytopenia; Transplantation, Homologous | 2006 |
Bortezomib after allografting in multiple myeloma: association between neurotoxicity and cyclosporine treatment.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Cyclosporine; Drug Interactions; Humans; Immunosuppressive Agents; Multiple Myeloma; Neoplasm Recurrence, Local; Peripheral Nervous System Diseases; Pyrazines; Transplantation, Homologous | 2007 |
A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Rate; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Failure; Vidarabine | 2008 |
[Trials of modulating the MDR1 phenotype in malignant hemopathies].
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Dexamethasone; Doxorubicin; Drug Resistance, Multiple; Humans; Leukemia, Myeloid, Acute; Multiple Myeloma; Quinine; Verapamil; Vincristine | 1994 |
T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease.
Topics: Adolescent; Adult; Alemtuzumab; Anemia, Aplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Lymphocyte Depletion; Male; Middle Aged; Multiple Myeloma; Transplantation, Homologous | 1994 |
VAD-cyclosporine therapy for VAD-resistant multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Liver Function Tests; Middle Aged; Multiple Myeloma; Survival Rate; Time Factors; Vincristine | 1995 |
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Drug Administration Schedule; Feasibility Studies; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Myeloma; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 1997 |
Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Case-Control Studies; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Prospective Studies; Survival; Tacrolimus | 1999 |
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
Topics: Adult; Aged; Aging; Cause of Death; Cyclosporine; Female; Graft Rejection; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Neutrophils; Platelet Count; Remission Induction; Survival Rate; T-Lymphocytes; Transplantation Conditioning; Whole-Body Irradiation | 2001 |
Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chi-Square Distribution; Cyclosporine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Proportional Hazards Models; Prospective Studies; Survival Rate; Vincristine | 2001 |
32 other study(ies) available for cyclosporine and Multiple Myeloma
| Article | Year |
|---|---|
Delayed-onset inflammatory polyneuropathy without graft versus host disease after bone marrow transplantation.
Topics: Anti-Inflammatory Agents; Bone Marrow Transplantation; Cyclosporine; Demyelinating Diseases; Female; Graft vs Host Disease; Humans; Immunization, Passive; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Multiple Myeloma; Polyneuropathies; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Young Adult | 2018 |
Bullous pyoderma gangrenosum secondary to underlying multiple myeloma: treated with ciclosporin.
Topics: Blister; Cyclosporine; Dermatologic Agents; Humans; Male; Middle Aged; Multiple Myeloma; Pyoderma Gangrenosum | 2019 |
Comment on 'Bullous pyoderma gangrenosum secondary to underlying multiple myeloma: treated with ciclosporin'.
Topics: Cyclosporine; Humans; Multiple Myeloma; Pyoderma Gangrenosum | 2019 |
Cyclophilin A as a downstream effector of PI3K/Akt signalling pathway in multiple myeloma cells.
Topics: Amino Acid Sequence; Base Sequence; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclophilin A; Cyclosporine; DNA Mutational Analysis; Humans; Hydroxybenzoates; Molecular Sequence Data; Multiple Myeloma; Mutant Proteins; Nitrofurans; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; STAT3 Transcription Factor | 2015 |
Drug-induced hypersensitivity syndrome after bortezomib treatment for refractory multiple myeloma.
Topics: Acyclovir; Antineoplastic Agents; Antiviral Agents; Boronic Acids; Bortezomib; Cyclosporine; Dexamethasone; Drug Hypersensitivity; Exanthema Subitum; Herpesvirus 3, Human; Herpesvirus 6, Human; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Prednisone; Pyrazines; Syndrome; Virus Activation | 2009 |
Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens.
Topics: Antigen Presentation; Antigens, Neoplasm; B-Lymphocytes; CD40 Antigens; Coculture Techniques; Cyclosporine; Humans; Immunotherapy; Insulin; Interleukin-4; Lymphocyte Culture Test, Mixed; Lymphokines; Multiple Myeloma; T-Lymphocytes, Cytotoxic; Th1 Cells; Transfection; Transferrin; Tumor Cells, Cultured | 2009 |
A case of severe cutaneous, GI and liver GVHD in a patient with multiple myeloma, status-post-second auto-SCT.
Topics: Cyclosporine; Fatal Outcome; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Liver Diseases; Middle Aged; Multiple Myeloma; Skin Diseases; Transplantation, Autologous | 2010 |
Graft-vs-host-disease-associated conjunctival chemosis and central serous chorioretinopathy after bone marrow transplant.
Topics: Antilymphocyte Serum; Bone Marrow Transplantation; Choroid Diseases; Conjunctival Diseases; Cyclosporine; Female; Fluorescein Angiography; Glucocorticoids; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methylprednisolone; Middle Aged; Multiple Myeloma; Retinal Diseases; Vision Disorders; Visual Acuity | 2002 |
Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning.
Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Chronic Disease; Cyclosporine; Disease Progression; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2003 |
Hemophagocytic lymphohistiocytosis after chemotherapy for multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Marrow; Cyclosporine; Dexamethasone; Etoposide; Histiocytosis, Non-Langerhans-Cell; Humans; Male; Middle Aged; Multiple Myeloma; Treatment Outcome | 2004 |
Rhabdomyolysis after concomitant use of cyclosporine and simvastatin in a patient transplanted for multiple myeloma.
Topics: Cyclosporine; Humans; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Male; Middle Aged; Multiple Myeloma; Rhabdomyolysis; Simvastatin; Stem Cell Transplantation | 2005 |
Bulbar palsy in multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Boronic Acids; Bortezomib; Bulbar Palsy, Progressive; Combined Modality Therapy; Cranial Fossa, Posterior; Cranial Nerve Diseases; Cyclosporine; Dexamethasone; Disease Progression; Doxorubicin; Fatal Outcome; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunoglobulin Light Chains; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Myeloma; Myeloma Proteins; Pneumonia, Aspiration; Pyrazines; Reflex, Abnormal; Transplantation, Homologous; Vincristine | 2005 |
Severe pancytopenia associated with a minor paroxysmal nocturnal haemoglobinuria clone and response to ciclosporin A in a heavily pretreated multiple myeloma patient.
Topics: Cyclosporine; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Myeloma; Pancytopenia | 2008 |
Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma.
Topics: Antigens, CD; Antigens, CD19; Antigens, Differentiation, B-Lymphocyte; ATP Binding Cassette Transporter, Subfamily B, Member 1; B-Lymphocytes; Carrier Proteins; Cyclosporine; DNA; Doxorubicin; Drug Resistance; Humans; Membrane Glycoproteins; Multiple Myeloma; Ploidies | 1994 |
Clinical modulation of multidrug resistance in multiple myeloma: effect of cyclosporine on resistant tumor cells.
Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; CD56 Antigen; Cyclosporine; Dexamethasone; Doxorubicin; Drug Resistance; Humans; Membrane Glycoproteins; Multiple Myeloma; Neoplasm Proteins; Plasma Cells; Vincristine | 1994 |
Objective response of multiple myeloma to cyclosporin A.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Dexamethasone; Doxorubicin; Humans; Male; Middle Aged; Multiple Myeloma; Vincristine | 1994 |
In vitro evaluation of chemosensitizers for clinical reversal of P-glycoprotein-associated Taxol resistance.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cyclosporine; Drug Resistance; Humans; Membrane Glycoproteins; Multiple Myeloma; Paclitaxel; Quinine; Trifluoperazine; Tumor Cells, Cultured; Verapamil | 1993 |
Long-term follow-up of monoclonal gammopathy of undetermined significance in transplant patients.
Topics: Contraindications; Cyclosporine; Follow-Up Studies; Heart Transplantation; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin kappa-Chains; Immunoglobulin lambda-Chains; Immunosuppression Therapy; Kidney Transplantation; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Time Factors | 1994 |
Increased neurotoxicity with VAD-cyclosporin in multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Dexamethasone; Doxorubicin; Humans; Multiple Myeloma; Nervous System; Vincristine | 1993 |
Thalidomide responsive chronic pulmonary GVHD.
Topics: Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Bronchiolitis Obliterans; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Multiple Myeloma; Thalidomide | 1996 |
Cardiotoxicity in the SCID mouse following administration of doxorubicin and cyclosporin A.
Topics: Animals; Antibiotics, Antineoplastic; Cell Transplantation; Chromatography, High Pressure Liquid; Cyclosporine; Doxorubicin; Drug Interactions; Heart Diseases; Humans; Kidney; Mice; Mice, Inbred BALB C; Mice, SCID; Multiple Myeloma; Myocardium; Neoplasm Transplantation; Rats; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 1995 |
Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; B-Lymphocytes; Biological Transport; Cyclosporine; Cyclosporins; Drug Resistance, Neoplasm; Humans; Immunosuppressive Agents; Multiple Myeloma; Rhodamine 123; Rhodamines; Tumor Cells, Cultured | 1998 |
Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myeloma.
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Multiple Myeloma; Transplantation, Homologous; Treatment Outcome | 1998 |
Immune recovery after bone marrow and peripheral blood stem cells transplantation.
Topics: Adult; Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Immunosuppressive Agents; Leukemia; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Multiple Myeloma; T-Lymphocytes; Transplantation, Autologous; Transplantation, Homologous | 1999 |
Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Breast Neoplasms; Chi-Square Distribution; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Graft vs Leukemia Effect; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; HLA-B Antigens; HLA-DR6 Antigen; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Prospective Studies; Transplantation, Autologous | 2000 |
Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis.
Topics: Acute Disease; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Isoantibodies; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Tacrolimus; Transplantation, Homologous | 2001 |
Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation.
Topics: Adult; Chediak-Higashi Syndrome; Cyclosporine; Fatal Outcome; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Depletion; Lymphocyte Transfusion; Male; Middle Aged; Multiple Myeloma; Mycophenolic Acid; T-Lymphocytes; Time Factors; Transplantation Chimera; Transplantation, Homologous; Treatment Failure; Vidarabine; Whole-Body Irradiation | 2001 |
Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Dexamethasone; Doxorubicin; Drug Interactions; Drug Resistance; Female; Humans; Male; Middle Aged; Multiple Myeloma; Prognosis; Prospective Studies; Vincristine | 1992 |
SDZ PSC-833--a novel potent in vitro chemosensitizer in multiple myeloma.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow; Cyclosporine; Cyclosporins; Doxorubicin; Drug Resistance; Drug Synergism; Humans; Immunohistochemistry; Membrane Glycoproteins; Multiple Myeloma; Tumor Cells, Cultured; Vincristine | 1992 |
Interferon-gamma potentiates the antitumor effect of cyclosporine-induced autoimmunity.
Topics: Animals; Autoimmunity; Cyclosporine; Disease Models, Animal; Drug Synergism; Female; HLA-D Antigens; Interferon-gamma; Multiple Myeloma; Rats; Rats, Inbred Strains; Recombinant Proteins; Tumor Cells, Cultured; Up-Regulation | 1992 |
[Lymphoproliferative syndromes after cardiac transplantation and treatment with cyclosporine. Report of 4 cases].
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Heart Transplantation; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Middle Aged; Multiple Myeloma; Prednisolone; Risk | 1992 |
An effective acute graft-vs.-host disease prophylaxis with minidose methotrexate, cyclosporine, and single-dose methylprednisolone.
Topics: Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Methylprednisolone; Multiple Myeloma; Myelodysplastic Syndromes | 1991 |